<bill session="103" type="h" number="916" updated="2010-04-19T01:28:51-04:00">
	<state datetime="1993-02-16">REFERRED</state>
	<status><introduced datetime="1993-02-16"/></status>

	<introduced datetime="1993-02-16"/>
	<titles>
		<title type="short" as="introduced">Prescription Drug Prices Review Board Act of 1993</title>
		<title type="official" as="introduced">To establish in the Food and Drug Administration the Patented Medicine Prices Review Board to regulate the prices of certain prescription drugs, to amend the Internal Revenue Code to recapture certain tax benefits, and for other purposes.</title>
	</titles>
	<sponsor id="400387"/>
	<cosponsors>
		<cosponsor id="402763" joined="1993-03-02"/>
		<cosponsor id="400553" joined="1993-03-08"/>
		<cosponsor id="400126" joined="1993-04-29"/>
		<cosponsor id="403314" joined="1993-03-08"/>
		<cosponsor id="400532" joined="1993-05-26"/>
		<cosponsor id="401494" joined="1993-03-24"/>
		<cosponsor id="400170" joined="1993-03-24"/>
		<cosponsor id="400538" joined="1993-05-26"/>
		<cosponsor id="401033" joined="1993-05-26"/>
		<cosponsor id="400306" joined="1993-03-24"/>
		<cosponsor id="400354" joined="1993-03-24"/>
		<cosponsor id="404375" joined="1993-03-24"/>
		<cosponsor id="403364" joined="1993-07-27"/>
		<cosponsor id="411350" joined="1993-08-03"/>
		<cosponsor id="400416" joined="1994-03-15"/>
		<cosponsor id="404520" joined="1993-07-01"/>
		<cosponsor id="401153" joined="1993-04-29"/>
		<cosponsor id="300156" joined="1993-05-26"/>
		<cosponsor id="400140" joined="1993-03-08"/>
		<cosponsor id="400378" joined="1993-05-26"/>
		<cosponsor id="400211" joined="1993-04-29"/>
		<cosponsor id="400390" joined="1993-03-08"/>
		<cosponsor id="400615" joined="1993-10-13"/>
		<cosponsor id="400595" joined="1993-03-08"/>
		<cosponsor id="404190" joined="1993-05-26"/>
		<cosponsor id="400357" joined="1993-03-02"/>
		<cosponsor id="400310" joined="1993-06-14"/>
		<cosponsor id="400223" joined="1993-06-14"/>
		<cosponsor id="404139" joined="1993-05-26"/>
		<cosponsor id="400314" joined="1993-03-08"/>
		<cosponsor id="400100" joined="1993-05-26"/>
		<cosponsor id="400537" joined="1993-03-08"/>
		<cosponsor id="400278" joined="1993-05-26"/>
		<cosponsor id="402762" joined="1993-04-29"/>
		<cosponsor id="400075" joined="1993-03-24" withdrawn="1993-04-22"/>
	</cosponsors>
	<actions>
		<action datetime="1993-02-16"><text>Referred to the House Committee on Energy and Commerce.</text></action>
		<action datetime="1993-02-16"><text>Referred to the House Committee on Judiciary.</text></action>
		<action datetime="1993-02-16"><text>Referred to the House Committee on Ways and Means.</text></action>
		<action datetime="1993-02-17"><text>Sponsor introductory remarks on measure. (CR H658-659)</text></action>
		<action datetime="1993-03-01"><committee name="House Committee on Energy and Commerce"/><text>Referred to the Subcommittee on Health and the Environment.</text></action>
		<action datetime="1993-03-24"><text>Sponsor introductory remarks on measure. (CR E760)</text></action>
		<action datetime="1993-05-05"><text>Sponsor introductory remarks on measure. (CR E1152-1153)</text></action>
		<action datetime="1993-05-13"><text>Sponsor introductory remarks on measure. (CR H2486)</text></action>
		<action datetime="1993-05-18"><text>Sponsor introductory remarks on measure. (CR E1273)</text></action>
		<action datetime="1993-05-25"><text>Sponsor introductory remarks on measure. (CR E1346)</text></action>
		<action datetime="1993-06-08"><text>Sponsor introductory remarks on measure. (CR E1419-1420)</text></action>
		<action datetime="1993-06-14"><text>Sponsor introductory remarks on measure. (CR E1486)</text></action>
		<action datetime="1993-06-16"><text>Sponsor introductory remarks on measure. (CR E1532-1533)</text></action>
		<action datetime="1993-06-17"><text>Sponsor introductory remarks on measure. (CR E1539)</text></action>
		<action datetime="1993-06-23"><text>Sponsor introductory remarks on measure. (CR E1598)</text></action>
		<action datetime="1993-07-13"><text>Sponsor introductory remarks on measure. (CR E1745-1746)</text></action>
		<action datetime="1993-07-14"><committee name="House Committee on Judiciary"/><text>Referred to the Subcommittee on Intellectual Property and Judicial Administration.</text></action>
		<action datetime="1993-07-27"><text>Sponsor introductory remarks on measure. (CR E1889)</text></action>
	</actions>
	<committees>
		<committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee" />
		<committee code="" name="House Energy and Commerce" subcommittee="Health and Environment" activity="Referral" />
		<committee code="HSJU" name="House Judiciary" activity="Referral, In Committee" />
		<committee code="HSJU-03" name="House Judiciary" subcommittee="Intellectual Property and Judicial Administration" activity="Referral" />
		<committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee" />
	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>
		<term name="Drugs"/>
		<term name="Advice and consent of the Senate"/>
		<term name="Congressional reporting requirements"/>
		<term name="Cost of living adjustments"/>
		<term name="Department of Health and Human Services"/>
		<term name="Drug industry"/>
		<term name="Excess profits tax"/>
		<term name="Executive reorganization"/>
		<term name="Income tax"/>
		<term name="Patents"/>
		<term name="Prescription pricing"/>
		<term name="Presidential appointments"/>
		<term name="Price regulation"/>
		<term name="Restrictive trade practices"/>
		<term name="Tax preferences"/>
		<term name="Taxation"/>
	</subjects>
	<amendments>

	</amendments>
	<summary>
	2/16/1993--Introduced.
Prescription Drug Prices Review Board Act of 1993 - Establishes in the Food and Drug Administration the Patented Medicine Prices Review Board which shall have the power to decrease the length of term of a prescription drug patent if, after notice and a hearing, it is found that the drug's price is excessive. Defines the term excessive price. Allows the Board to require the recapture of tax benefits provided to the patentee of an excessively priced drug.

	</summary>
</bill>
